Materia Health: Seeking Partners for Precision Temperature-Controlled Transport for Equine & Livestock Sperm
Opportunity for
- Stud farms, breeders and veterinary operators involved in equine and high-value livestock reproduction
- Research organisations and universities with expertise in reproductive biology, sperm viability and preservation
- Industry partners able to support trials, validation and real-world deployment
- Commercial partners or early adopters interested in piloting next-generation cell preservation technologies
Industry challenge
Across animal health and reproductive systems, the preservation and transport of reproductive material continues to rely heavily on passive cooling methods with limited temperature control. In equine and other high-value livestock breeding, sperm cells are highly sensitive to temperature fluctuations, yet are commonly transported in basic foam containers with ice packs. This leads to variability in cell viability, contributes to failed conception attempts, and places significant financial and operational risk on breeders, stud farms, and owners.
This challenge is further amplified in Australia, where ambient temperatures are variable and frequently exceed optimal ranges for cell preservation. Even minor deviations can reduce reproductive success – an important consideration when genetics and performance traits drive commercial value. As breeding operations increasingly depend on transported genetic material, there is a growing need for reliable, controlled preservation systems that minimise variability, protect sample integrity, and improve conception outcomes across the supply chain.
Current opportunity
Materia Health has developed a portable, battery-powered preservation device that actively manages temperature, moving beyond traditional passive cooling methods. The system uses proprietary software algorithms to deliver precise, species-specific temperature control across a range of ambient conditions, including the capability to cool, maintain room temperature and rewarm, within a single reusable platform.
The company is seeking partners to support validation and applied trials in equine and high-value livestock settings, with a focus on real-world workflows such as sperm transport from stud farms to breeders. Ideal partners can provide trial environments, technical or scientific input, and feedback on integration into existing breeding systems.
In return, partners gain early access to a differentiated preservation technology, the opportunity to shape product development, and the potential to improve reproductive outcomes, reduce transport-related losses, and de-risk the transfer of high-value genetic material.
Opportunity background
Materia Health is a Perth-based, early-stage medical technology company founded by a medical doctor, with core technology developed for the preservation of donor organs and tissues for transplantation.
The platform is now being adapted for Defence applications to enable blood resuscitation in austere environments, as well as for veterinary use to improve artificial insemination success, leveraging the same underlying principle of ex vivo, cell-specific temperature preservation.
The company is progressing through mid-TRL development and is actively building partnerships to accelerate validation and commercialisation.
Potential other applications
Beyond its existing healthcare, defence and veterinary applications, Materia Health’s technology has potential across a range of sectors that require reliable preservation of sensitive biological materials, including pharmaceutics, diagnostics, and rural and remote medicine.
Materia Health is open to exploring collaborations in adjacent fields where precision temperature management during transportation can drive meaningful commercial, operational, and logistical gains.